|
CDC Chronic Kidney Disease Surveillance
|
Health Survey
|
CDC
|
NIDDK
|
NIDDK assists CDC in their surveillance program of chronic kidney disease.
|
|
CDC Community Guide: Review various interventions to reduce alcohol-related problems
|
Resource Development
|
CDC, SAMHSA
|
NIAAA, NIDA
|
The Community Guide is a free resource to help people choose the most effective programs and policies to improve health and prevent disease in their communities.
|
|
CDC Elimination of Pediatric HIV in US Stakeholders Group
|
Other
|
CDC
|
NICHD
|
Working group of federal and non-federal individuals to assist CDC in developing initiatives to eliminate mother to child HIV transmission in the US.
|
|
CDC Pediatric HIV Case Definition Working Group
|
Other
|
CDC
|
NICHD
|
Advises on development of new pediatric HIV surveillance definition.
|
|
CDC Sexually Transmitted Diseases Guidelines
|
Other
|
CDC
|
NICHD
|
Working group of CDC that develops guidelines for treatment of STD.
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Other
|
CDC, OS
|
NIAID
|
Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the CDC. CDC and NIH both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development.
|
|
CDC-NIOSH (For Audiometric Support for Two NIDCD-Sponsored, Population-Based Hearing Examination Surveys)
|
Health Survey
|
CDC
|
NIDCD
|
The purpose of this agreement is to provide funding for scientific and technical support as well as quality assurance of two large audiometric examination surveys funded by NIDCD. The two surveys are: The National Health and Nutrition Examination Survey (NHANES) and (ii) Age, Gene/Environment Susceptibility Study–Reykjavik Study (AGES–RS). The Audiometry Components of both the NHANES and AGES–RS were previously developed by NIDCD in collaboration with NIOSH and other consultants. NIOSH collaborated on the design of the experimental protocol and provided the equipment specifications, oversight of maintenance and calibration, technician training and oversight, operations manual development, and quality assurance for the NHANES. As well, NIOSH provided similar support to AGES, including site visits for training and observation, technical assistance, and limited quality assurance. The NHANES scientific goals are to establish a statistically accurate, demographically representative baseline on the general health (including Hearing Health) of the U.S. population. NHANES is now a continuous survey and while general health issues are always under investigation such as height, weight and blood pressure, there are also elements that track individual health outcomes that move in and out of the NHANES as it cycles. NHANES consists of two major components: the household interview and the physical examination in the NHANES Mobile Examination Centers (MECs) that are set up in various areas around the country. The data from the NHANES elements are collected, weighted, and made available to the government and the public as a database on which analysis may be performed. Recently, the data have been released every two years with collaborating agencies receiving the data six months prior to the public release of the data sets. The AGES–RS scientific goals are: 1) to identify genetic and new risk factors for selected diseases including atherosclerosis, cognitive impairment, dementia, stroke, hearing loss, visual impairment, sarcopenia, osteoporosis, and obesity, 2) to characterize phenotypes for these diseases and conditions, and 3) to identify contributory molecular markers associated with these conditions. Both AGES–RS and NHANES share a similar hearing component, developed collaboratively by NIDCD, NIOSH, NCHS, and the Icelandic Heart Association Research Institute. The hearing component consists of: 1) a set of questionnaires relating to hearing, noise exposure, and other factors relating to hearing, and 2) audiometric examinations consisting of otoscopy, acoustic immittance (bilateral tympanometry and screening for ipsilateral acoustic reflexes at 1000 and 2000 Hz), and pure-tone, air-conduction audiometry to determine the hearing thresholds in each ear at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz. A repeat threshold test is obtained at 1000 Hz as a measure of test reliability. When significant inter-ear differences are found, then retests are performed using insert earphones to maximize the inter-aural attenuation rather than using a noise masker of the non-test ear to obtain what is referred to as masked threshold in the in the test ear, thus avoiding a “shadow audiogram” from the better non-test ear.
|
|
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/OAR
|
The CDC / HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment shall advise the Secretary; the Director, CDC; and the Administrator and Associate Administrator for HIV/AIDS, HRSA, regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts including surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis.
|
|
CDC/NIH Urine Calibration Study
|
Research Initiative
|
CDC
|
NHLBI, OD/DPCPSI
|
Because of the logistic complexity, high respondent burden, and high cost of conducting 24-hour urine collections in national surveys, alternative strategies to monitor sodium intake at the population level need to be evaluated. This study is designed to assess the ability to characterize population sodium intake from one or more timed-spot urines calibrated to a 24-hour urine collection. NHLBI convened a working group in 2011 to advise us on the design of the study. One of two studies was conducted in 2012 in younger adults and led by CDC. The second study in older adults is planned for 2013 and will be led by NHLBI. Several manuscripts authored by CDC and NIH staff based on the first study are in preparation or have been submitted.
|
|
CDC’s Field Epidemiology Training Program (FELP) Cancer Curriculum
|
Training Initiative
|
CDC
|
NCI
|
CDC and NCI (CGH and Cancer Prevention Fellowship Program) are collaborating to add a cancer curriculum to CDC’s Field Epidemiology Training Program.
|